A phase II study of everolimus in patients with advanced solid malignancies with TSC1, TSC2, NF1, NF2 or STK11 mutations.
Journal Of Thoracic Disease
Devarakonda, Siddhartha S; Pellini, Bruna B; Verghese, Luke L; Park, Haeseong H; Morgensztern, Daniel D; Govindan, Ramaswamy R; Suresh, Rama R; Oppelt, Peter P; Baggstrom, Maria Q MQ; Wu, Ningying N; Waqar, Saiama N SN